Fulminant hepatitis B virus (HBV) infection in an infant following mother-to-child transmission of an e-minus HBV mutant: Time to relook at HBV prophylaxis in South African infants.

The prevalence of hepatitis B virus (HBV) infection in pregnant women is high in South Africa (SA), yet prophylaxis to prevent mother-to-child transmission (MTCT) falls short of international recommendations. We describe a 10-week-old infant who developed fulminant hepatic failure following MTCT. The mother was hepatitis e-antibody positive and had a viral load of only 760 IU/mL. Genetic analysis of virus from mother and infant showed that both had the G1896A mutation in the preC/C gene, which truncates hepatitis e antigen (HBeAg) during translation, causing an HBeAg-negative phenotype. HBeAg attenuates antiviral immune responses, and its absence was probably responsible for the infant's fulminant hepatitis, due to an uncontrolled immune attack on infected liver cells. Pregnant women are not tested for HBV infection in SA and MTCT rates are unknown. Addition of a birth dose of vaccine, HBV screening of pregnant women and antiviral prophylaxis to positive mothers should be prioritised.

[1]  Jianguo Wu,et al.  Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action , 2017, Scientific Reports.

[2]  H. Smuts,et al.  Hepatitis B Virus Genotype G: First Report of Complete Genomic Analysis from the African Continent , 2017 .

[3]  Hepatitis B vaccines: WHO position paper – July 2017. , 2017, Releve epidemiologique hebdomadaire.

[4]  Yongfang Jiang,et al.  Molecular mechanisms of HBeAg in persistent HBV infection , 2016, Hepatology International.

[5]  R. Pattinson,et al.  Antenatal screening for hepatitis B virus in HIV-infected and uninfected pregnant women in the Tshwane district of South Africa. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[6]  M. Cotton,et al.  Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. , 2015, Vaccine.

[7]  R. Mohamed,et al.  Universal Primers for Detection and Sequencing of Hepatitis B Virus Genomes across Genotypes A to G , 2015, Journal of Clinical Microbiology.

[8]  H. Hsu,et al.  Infantile Hepatitis B in Immunized Children: Risk for Fulminant Hepatitis and Long-Term Outcomes , 2014, PloS one.

[9]  R. Parboosing,et al.  Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting. , 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[10]  R. Chaisson,et al.  Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa , 2014, Journal of the International AIDS Society.

[11]  R. Tedder,et al.  The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa☆ , 2013, Vaccine.

[12]  A. Kramvis,et al.  Genotyping and Molecular Characterization of Hepatitis B Virus from Human Immunodeficiency Virus-Infected Individuals in Southern Africa , 2012, PloS one.

[13]  H. Hsu,et al.  Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. , 2012, Gastroenterology.

[14]  H. Zhuang,et al.  Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients. , 2010, Antiviral research.

[15]  Y. Wen,et al.  Biological features of hepatitis B virus isolates from patients based on full‐length genomic analysis , 2009, Reviews in medical virology.

[16]  M. Kew,et al.  Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  Mimi C. Yu,et al.  Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu‐speaking sub‐saharan Africans , 2005, Journal of medical virology.

[18]  H. Coovadia,et al.  The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy. , 2003, Archives of pediatrics & adolescent medicine.

[19]  P. Venter,et al.  The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. , 2001, Vaccine.

[20]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.

[21]  H. Coovadia,et al.  The prevalence and transmission of hepatitis B virus infection in urban, rural and institutionalized black children of Natal/KwaZulu, South Africa. , 1988, International journal of epidemiology.

[22]  A. Dibisceglie,et al.  Prevalence of hepatitis B virus infection among black children in Soweto. , 1986, British medical journal.

[23]  G. Dusheiko,et al.  HEPATITIS B VIRUS CARRIER STATE IN BLACK CHILDREN IN OVAMBOLAND: ROLE OF PERINATAL AND HORIZONTAL INFECTION , 1984, The Lancet.